Maghreb Edition

Algeria: Diphtheria Death Sparks Outbreak Fears in Skikda

Posted On 19 October 2025

Number of times this article was read : 243

The province of Skikda is experiencing anxiety after the announcement on Thursday of a death caused by diphtheria. This resurgence of a disease once believed to be eradicated has immediately placed the region on high public health alert.

The local health authority released a statement confirming the fatality and reported several other infections, some of which are classified as “serious.”

Diphtheria: The “Silent” Threat Returns in Algeria

Once controlled through vaccination campaigns, diphtheria—caused by the bacterium Corynebacterium diphtheriae—is now resurging and causing concern among the public. Health officials are warning citizens not to ignore early symptoms: a sore throat, difficulty swallowing, and severe fatigue.

What is most alarming is how quickly the infection can progress. Diphtheria is known as a “silent” illness in its initial stages because it produces a potent toxin that can cause severe cardiac complications (myocarditis) and neurological damage. If diagnosis and treatment are delayed, the disease can be fatal. Mortality rates among untreated cases range from 5% to 10%, underlining the seriousness of this bacterial infection.

Prevention: The Critical Role of Vaccination

In response, authorities are unified in their message: vaccination is the only truly effective defense.

The Skikda Health Directorate is urgently urging all residents to go “immediately” to vaccination centers. The message highlights two key priorities:

“For adults: Get the required booster dose (the DTP/DT vaccine should be given as a booster every ten years). For children: Ensure that all vaccinations are up to date according to the national immunization schedule.”

Residents of Skikda and Filfila communities are named as priority areas for this catch-up vaccination campaign.

Recognizing the Signs of Diphtheria

Diphtheria is usually spread through respiratory droplets (coughing or sneezing) and is marked by the formation of a thick, gray membrane in the throat, which can cause suffocation. When the bacteria are infected by a bacteriophage, they produce a toxin that targets the heart and nervous system.

Treatment is a race against time and requires rapid intervention, including the immediate use of antitoxin upon suspicion, followed by antibiotics to eradicate the bacteria. Community-wide mobilization is essential to halt this resurgence and prevent more lives from being lost to this “disease of the past.” *Vaccination remains, as ever, the frontline defense in public health.

The North Africa Journal's WhatsApp Group
.

Most Recent Stories from the Region

Moroccan Streamer Ilyas El Maliki Arrested Again

Moroccan streamer Ilyas El Maliki was arrested 25 November 2025 in El Jadida, following a police summons tied to a defamation complaint; details remain under investigation while public scrutiny grows.

Morocco: Ex-Minister and Lawyer, Mohamed Ziane Still in Detention

Morocco’s former minister Mohamed Ziane remains in detention due to two separate criminal cases, one finalized and one still under cassation review. Authorities argue the detention is legally required, while international rights groups challenge aspects of the proceedings.

Written by The North Africa Journal

The North Africa Journal is a leading English-language publication focused on North Africa. The Journal covers primarily the Maghreb region and expands its general coverage to the Sahel, Egypt, and beyond, when events in those regions affect the broader North Africa geography. The Journal does not have any affiliation with any institution and has been independent since its founding in 1996. Our position is to always bring our best analysis of events affecting the region, and remain as neutral as humanly possible. Our coverage is not limited to one single topic, but ranges from economic and political affairs, to security, defense, social and environmental issues. We rely on our full staff analysts and editors to bring you best-in-class analysis. We also work with sister company MEA Risk LLC, to leverage the presence on the ground of a solid network of contributors and experts. Information on MEA Risk can be found at www.MEA-Risk.com.